Click to Share
 

Infectious Disease Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

12535353
By SMi Group
At the forefront of combating the serious global threat of antimicrobial resistance (AMR) for almost two decades, the infectious disease industry's premier event returns to London next month on 16th and 17th March.
By Zika Response Working Group
The Zika Response Working Group is a coalition of researchers, academics, industry leaders and companies. We all have one goal.
By EUROIMMUN US
EUROIMMUN Creates a Paradigm Shift in ANA Testing through the FDA clearance of its EUROPattern Computer Aided Immunofluorescent Microscope.
By ProKure Solutions
PHOENIX---ProKure V, a readily available, EPA-registered hospital disinfectant that kills some of the most notorious viruses threatening people's health today, has the power to begin destroying the Ebola virus on surfaces in a matter of seconds.
By Kalorama Information
Kalorama Information announces the publication of "The Market and Potential for Molecular Point of Care Diagnostics."
12099764
By Strategic Book Group
Learn about the Three Major Challenges to Humanity in the 21st Century from Dr. Adesola Lajide, a physician, clinical epidemiologist, and bio-statistician working with the Oyo State Ministry of Health in Nigeria.
12063712
By Cochrane & Associates, LLC
UVDI’s V-360° Room Sanitizer® is deployed to eliminate superbugs and provide optimum patient care at Presbyterian Hospitals in Albuquerque.
12063333
By SMi Group
Focusing on combating multidrug resistance, R&D regulations and implementing public and private partnerships, SMi is proud to present their 15th annual conference on Superbugs and Superdrugs the only event of its kind in Europe
By PATH OneWorld Health
Announces the successful completion of phase3(b) clinical trials on PMIM, a treatment for isceral leishmaniasis (VL or kala-azar). It then outlines the methods used and gives an overview of the treatment and the disease.
12021254
By Cochrane & Associates, LLC
The professionals at EC2 provide indoor air quality (IAQ) testing services to identify indoor environments conducive to fungal infections.
By Cochrane & Associates, LLC
The IAQ Video Network produces another educational video about infectious diseases, indoor air quality (IAQ), pathogens and toxins.
By Cochrane & Associates, LLC
The IAQ Video Network produces another educational video about microbial pathogens, toxins and health hazards.
By Cochrane & Associates, LLC
The IAQ Video Network produces another educational video about microbial pathogens.
By Cochrane & Associates, LLC
The IAQ Video Network produces another educational video about health threats due to exposure to environmental contaminants and pathogens.
By Cochrane & Associates, LLC
The IAQ Video Network produces another educational video about health threats due to exposure to environmental contaminants and pathogens.
By Level4 Bio, LLC
Level4 Bio launches the first safe power sanitizing service for killing surface and airborne pathogens in any environment. The technology is patented, registered with the FDA as a medical device, EPA approved and UL certified.
By Cochrane & Associates, LLC
The IAQ Video Network informs and educates the public about important indoor air quality (IAQ), environmental and microbial pathogen issues.
11717729
By Cochrane & Associates, LLC
The environmental experts at Sussex Environmental Health Consultants identify and help prevent outbreaks of microbial pathogens.
By Cochrane & Associates, LLC
The IAQ Video Network’s videos inform and educate the public about important indoor air quality (IAQ), environmental and microbial pathogen issues.
11689030
By Cochrane & Associates, LLC
The environmental and infection control professionals at Clark Seif Clark (CSC) provide services to help prevent outbreaks of norovirus.

All Press Releases

By ProCE, Inc. and SIDP
ProCE, Inc. 848 W. Bartlett Road, Suite 3E Bartlett, IL 60103 630.540.2848 Press Contact: Richard Lewis, PharmD, MBA Society for Infectious Disease Pharmacy (SIDP) 823 Congress Avenue, Ste 230 Austin, TX 78701 512.328.8632 Press Contact: Jason Gallagher,.
By Market Reports Center
Global Viral Infections Market to 2021 - Promising New Competitors and Expanding Treatment Population to Offset Increased Uptake of Generics
12535353
By SMi Group
At the forefront of combating the serious global threat of antimicrobial resistance (AMR) for almost two decades, the infectious disease industry's premier event returns to London next month on 16th and 17th March.
By Zika Response Working Group
The Zika Response Working Group is a coalition of researchers, academics, industry leaders and companies. We all have one goal.
By SMi Group
SMi Group is thrilled to announce that agenda has now been released for the 18th annual conference on Superbugs & Superdrugs, set to take place on 16th and 17th March 2016 in London, UK
By CNBE INRS
Strategic partnership and development agreement between the Claude Bourgelat Institute (France) and the INRS Centre national de biologie expérimentale (Québec) for in vivo preclinical studies in the area of human and animal health Two scientific teams,...
By EUROIMMUN US
EUROIMMUN Creates a Paradigm Shift in ANA Testing through the FDA clearance of its EUROPattern Computer Aided Immunofluorescent Microscope.
By Informa Life Sciences Exhibitions
Antibiotic resistance and its concequences are key topics at MEDLAB Asia Pacific 2015
By EH&E, Inc.
Available Time to Train Staff, Certifications to Ship Hazardous Materials are Top Challenges Facing Hospitals in Ebola Preparedness, States EH&E Survey
By ProKure Solutions
PHOENIX---ProKure V, a readily available, EPA-registered hospital disinfectant that kills some of the most notorious viruses threatening people's health today, has the power to begin destroying the Ebola virus on surfaces in a matter of seconds.
By WiRED International
“The number one problem in controlling Ebola and other infectious diseases is ignorance,” declares a former surgeon general of the U.S. Navy. Retired Vice Admiral Adam M.
By Kalorama Information
Kalorama Information announces the publication of "The Market and Potential for Molecular Point of Care Diagnostics."
By Kalorama Information
Immunoassays conducted for the purpose of determining the presence of infectious disease in a patient lead the market for this important IVD test, both in size of market and in the rate of revenue growth, according to Kalorama Information.
By Kalorama Information
The world market for infectious disease tests is estimated at $14.5 billion in 2012 and with 5% CAGR will reach $18.3 billion in 2017, according to Kalorama Information's latest report “The World Market for Infectious Disease Diagnostic Tests.”
By Kalorama Information
The world market for infectious disease tests is estimated at $14.5 billion in 2012 and should grow at a slightly higher rate than the rest of the diagnostics market. The finding was made in "The World Market for Infectious Disease Diagnostic Tests."
By Cambridge Healthtech Institute
Jim Huggett, B.Sc. (Hons), Ph.D., Science Leader, Nucleic Acid Metrology, Molecular & Cell Biology, LGC to give keynote address, “Digital PCR: A Paradigm Shift in Molecular Measurement,” at Second Annual Digital PCR Conference in San Diego.
12099764
By Strategic Book Group
Learn about the Three Major Challenges to Humanity in the 21st Century from Dr. Adesola Lajide, a physician, clinical epidemiologist, and bio-statistician working with the Oyo State Ministry of Health in Nigeria.
By Cochrane & Associates, LLC
The IAQ Video Network releases another educational video about indoor air quality (IAQ), toxins, pathogens or environmental issues.
12063712
By Cochrane & Associates, LLC
UVDI’s V-360° Room Sanitizer® is deployed to eliminate superbugs and provide optimum patient care at Presbyterian Hospitals in Albuquerque.
12063333
By SMi Group
Focusing on combating multidrug resistance, R&D regulations and implementing public and private partnerships, SMi is proud to present their 15th annual conference on Superbugs and Superdrugs the only event of its kind in Europe
By GlobalMed
The GlobalMed TotalExam™ HD camera may help to prevent the spread of infectious diseases by allowing physicians to accurately diagnose a patient remotely.
By PATH OneWorld Health
Announces the successful completion of phase3(b) clinical trials on PMIM, a treatment for isceral leishmaniasis (VL or kala-azar). It then outlines the methods used and gives an overview of the treatment and the disease.
By Cochrane & Associates, LLC
The infection control and indoor air quality experts at EC2 help identify the microbial pathogen responsible for histoplasmosis.
12021254
By Cochrane & Associates, LLC
The professionals at EC2 provide indoor air quality (IAQ) testing services to identify indoor environments conducive to fungal infections.
By Cochrane & Associates, LLC
The IAQ Video Network produces another educational video about infectious diseases, indoor air quality (IAQ), pathogens and toxins.
By Cochrane & Associates, LLC
Leading maker of medical grade UV disinfection products engineered for the healthcare industry adds veteran professional to the team.
By Cambridge Healthtech Institute
CHI to host three problem solving breakout discussions at the Mass Spectrometry in Diagnostics of Infectious Disease and Clinical Microbiology conference, Aug. 21-22, 2012, Washington, DC.
By Cochrane & Associates, LLC
The IAQ Video Network produces another educational video about microbial pathogens, toxins and health hazards.
By Cochrane & Associates, LLC
The IAQ Video Network produces another educational video about microbial pathogens.
By Trovagene, Inc.
Diagnostic Company Reports Gross Proceeds from Recent PO Estimated to be $9.2 Million

Page:
Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share